Natera Inc (NTRA) — Technical state
As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 42 out of 100 (momentum 72 · quality 24 · valuation 7), as of 2026-11-11.
- Signal: Resizing — 26.8% off its high — 26.8% below its 52-week high — a deeper resizing of the trend, not a shallow dip. (as of 2026-11-09)
- Trend: Natera Inc trades 15.7% below its 50-day and 18.8% above its 200-day moving average. (as of 2026-11-09)
- Index seat: HALO Growth 100
Natera develops molecular diagnostic tests that read DNA fragments from blood or tissue to flag disease markers or genetic risk. Its lines include Signatera, which tracks circulating tumour DNA to monitor cancer recurrence and treatment response; Panorama, a non-invasive prenatal screen; Horizon, a carrier screening test; Empower, a hereditary cancer screen; and Prospera, which checks for rejection after organ transplants.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the NTRA overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
26.8% below its 52-week high — a deeper resizing of the trend, not a shallow dip.
Ranked #47 on today’s Directional Flow — Top scores list (scan of 2026-11-10).
The moving-average stack
- vs 20-day-18.4%
- vs 50-day-15.7%
- vs 200-day+18.8%
- 52-week band26.8% off the high · +91.6% off the low
- Streak1 consecutive up session
- 50-day crossprice crossed down through the 50-day 3 sessions ago
- Stochastic%K 9.8 · %D 15.9
Continue: the NTRA chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-09
Quick answers
What is the current Closelooknet signal on NTRA?
Resizing — 26.8% off its high — 26.8% below its 52-week high — a deeper resizing of the trend, not a shallow dip. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is NTRA above its 50-day and 200-day moving averages?
As of 2026-11-09, Natera Inc trades -15.7% below its 50-day and +18.8% above its 200-day average, with the 20-day -18.4% away.
How far is NTRA from its 52-week high?
26.8% below the 52-week high and 91.6% above the 52-week low, as of 2026-11-09.
Mentioned on Closelooknet
Where NTRA appears in the diary — 2 pieces, newest first. Every link is our own writing.
Long reads
- Agentic Application Software: The SaaSpocalypse Map
Veeva (VEEV) · Tempus AI (TEM) · Natera (NTRA) · Intuitive Surgical (ISRG) Valuation Multiples vs.
Dailies
- AI Builders — Chips Bounce 4%, AMD Jumps 10% and IREN 20% After a Strong Jobs Report
After results — DraftKings sinks 27%, Natera 15%
Related in the Closelooknet universe
same Closelooknet index seat first, then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- RACE Ferrari NV
- LLY Eli Lilly and Company
- REGN Regeneron Pharmaceuticals Inc
- DXCM DexCom Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- GMED Globus Medical
- ONON On Holding Ltd
- VRSK Verisk Analytics Inc
- FAST Fastenal Company
- IDXX IDEXX Laboratories Inc
- ZEAL.CO Zealand Pharma A/S
- MEDP Medpace Holdings Incindustry
- ILMN Illumina Incindustry
- ICLR ICON PLCindustry
- GH Guardant Health Incindustry
- CDNA CareDx Incindustry
- MTD Mettler-Toledo International Incindustry
- LH Labcorp Holdings Inc.industry
- CRL Charles River Laboratoriesindustry